News

The German Research Foundation (DFG) will fund single-cell scientist Simon Haas in its Heisenberg program. Therefore, the Berlin Institute of Health at Charité (BIH) is establishing a Heisenberg professorship in systems hematology. After five years, the BIH will make the professorship permanent.

The international BioRescue consortium in Berlin has announced that for the first time a rhino has successfully become pregnant following embryo transfer. This paves the way for using of the same method of reproductive medicine to save the northern white rhino from extinction.

Big data, the opportunities of precision medicine, recent advances in organoid technology, and new developments in proteomics: Berlin's Senator for Higher Education and Research, Health and Long-Term Care, Ina Czyborra, visited the Max Delbrück Center in early January to learn about the latest developments in biomedicine.

Working in Berlin-Mitte and New York – Lena Nitsch conducts research at both the MDC-BIMSB and New York University. For “We at the MDC”, the doctoral student discusses how it is to work in two labs, her experiences in the United States, and what she has learned through the “MDC-NYU PhD Exchange Program”.

The European Molecular Biology Organization has selected Leif. S. Ludwig from the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center to become an EMBO Young Investigator. The program provides support to outstanding young life scientists.

There are few pregnancy diseases as life-threatening as preeclampsia. But the danger doesn’t end after birth: Mothers with preeclamptic pregnancies have a much higher risk of developing cardiovascular disease later in life. Kristin Kräker from the Experimental and Clinical Research Center is working on an early warning system.

An afternoon marked by innovation: Berlin's Mayor, Kai Wegner, visited the Max Delbrück Center on October 11, 2023, and subsequently inaugurated the BerlinBioCube innovation center on the Buch research campus. The BioCube, in close proximity, provides state-of-the-art laboratories and offices for life science startups and spin-offs, including those from the Max Delbrück Center.

People with hypertension are at the greatest risk of developing serious cardiovascular diseases. A team of researchers at the Experimental and Clinical Research Center are now investigating whether probiotics in food supplements can support drug therapies or even delay the need to start them.

It borders on the miraculous how an entire animal emerges from a single egg cell. In order to understand the underlying molecular mechanisms, Markus Mittnenzweig is establishing the Computational and Developmental Biology Lab at the Max Delbrück Center.